• About
  • Subscribe
  • Advertise
  • Contact
Tuesday, May 20, 2025
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home Report

Australian eyewear tariff: How can we accept this? – David Pearson

by Staff Writer
February 6, 2024
in Report, Soapbox
Reading Time: 5 mins read
A A
Safilo Eyewear Tariffs

David Pearson says that the government should determine if imposing tariffs is a good idea before implementing them. Image: Safilo.

Share on FacebookShare on Twitter

 

The recent introduction of tariffs on spectacle frames has no effect on Australian manufacturing, highlights the weakness of the border force regulatory system and shows the damage that can be done to an industry by a single disgruntled entity.

A quick recap: in mid-2022, an Australian eyewear company requested that a 5% tariff be imposed on the import of plastic spectacle frames. Further, this tax was then extended to cover metal spectacle frames in 2023. The motivation was that imposing a tax on spectacle imports would help Australian eyewear manufacturing. You would think that with extensive federal public service resources at hand, this type of request would garner detailed scrutiny to evaluate its effectiveness – that it couldn’t be possible to introduce a 5% tax on a majority of frame imports without some detailed explanation? Unfortunately not. A short submission from one company was all it took to introduce a tax costing the industry millions.

It is correct that this tax only applies to imports from countries where Australia doesn’t have a free trade agreement (FTA) – China being one of the main manufacturers where we have an FTA. Unfortunately, most brands that manufacture in China (which is significant) consolidate the goods from the many suppliers in central warehouses located in Europe. The recent break-down in negotiations over an FTA with the EU means the tax still applies (it’s not where the goods are manufactured, it is where they are shipped from), and the government continues to collect its payments at the border.

So who pays? A nuanced issue no doubt, and one that could be long-debated. But in reality, the price gets passed firstly on to retailers and then consumers. With all the talk of a government doing what it can to “lower the cost of living”, here is a concrete example of the opposite. However, a second, more regrettable outcome is that the tax gets paid by reduced investment in local businesses. Spectacle frame wholesaling is competitive, and while we all still see the Australian market as strong and stable with a good future, nothing dents confidence like the imposition of new/unforeseen taxes with no basis.

The large chains that purchase direct from China factories may have escaped this tax, while the locally owned distributors and subsidiaries are bearing the cost disproportionately along with independent retailers who purchase from local companies. These wholesalers are the companies that are the main employers of the spectacle supply industry – not Australian manufacturers. A 5% increase in the cost of goods, on top of inflationary pressures, is more than enough to reconsider the employment of the additional warehouse worker, the renewal of the office IT infrastructure, the advertising campaign spend or the practice point-of-sale creation. Thinking that this tax miraculously has no impact on investment decisions is a fantasy.

And the outcome for Australian spectacle manufacturing? We didn’t see any presence at recent trade shows, no advertising in trade magazines or any recruitment for more reps to push the Australian made frames. Even in the words of the company that prompted the imposition of the tax, the “tariff won’t make a monetary difference to my business” (Insight, June 2022). Please make no mistake, supporting Australian manufacturing is a great initiative. Safilo Australia has recently launched the FULL CIRCLE program and SMITH RX partnership with CR Labs, an Australian manufacturer which is a true success story of Australian made. Adam and his team at CR compete because they manufacture great quality product, bring innovation and support to optical practices, and do it locally with a highly skilled workforce at a competitive price. We are proud to be associated with CR Labs.

In the end, the solution to this mess is for Australian Border Force, and the relevant federal minister (Clare O’Neil), to actually understand the impact of their decisions. A tax has been imposed that has no benefit to the Australian economy and no-one has asked “why?”.  In our wonderful democracy, it’s fine for a company to try and make costs higher for everyone else, but it should be the role of the government who collects those taxes to at least check if it is a good idea. It is unacceptable that taxes can be imposed without any decent scrutiny, and even more unacceptable that the representations of our industry body have been ignored by those imposing the tax.

In the overall federal budget, the revenue from this tax is an extremely small issue, it’s difficult to explain and affects an industry without much political power. However, the principal eats away at the credibility of government and the public service. Let’s not storm the capital, but as an industry we shouldn’t accept poor decisions. 

About the author

Name: David Pearson
Affiliations: Safilo, senior director APAC
Location: Sydney

More reading

The future of cataract surgery – A/Prof Michael Lawless

Myopia management is more than clinical acumen – Matt Oerding

AI, fundus imaging and life-threatening headaches

Related Posts

geographic atrophy treatments

Exploring geographic atrophy: Managing patients and progress in treatments

by Rob Mitchell
May 20, 2025

At the completion of this article, the reader should be able to: Manage patient expectations and adherence to treatment, in...

Esther Ndukwe. Image: Specsavers.

Specsavers Stories – Esther Ndukwe

by Staff Writer
May 20, 2025

When people decide to work at Specsavers, they’re joining a company with a purpose to change lives through better sight and...

A patient’s right to access may include being provided with a copy of their records, inspecting them, and providing a copy to an authorised third party. Image: pandpstock001/Shutterstock.com.

Can I have a full copy of my medical records?

by Staff Writer
May 19, 2025

Blanket requests to obtain medical records can blindside and overwhelm an unsuspecting practice, so how should they be handled? Georgie...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited